Santibáñez Miguel, Garrastazu Roberto, Ruiz-Nuñez Mario, Helguera Jose Manuel, Arenal Sandra, Bonnardeux Cristina, León Carlos, García-Rivero Juan Luis
Preventive Medicine and Public Health Area, Universidad de Cantabria-IDIVAL, Santander, Cantabria, Spain.
Centro de Salud de Gama, Servicio Cántabro de Salud, Bárcena de Cicero, Cantabria, Spain.
PLoS One. 2016 Jun 30;11(6):e0158727. doi: 10.1371/journal.pone.0158727. eCollection 2016.
Exacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs-particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their determinants. This study aimed to analyze predictors of hospitalized exacerbations and mortality in COPD patients.
This was a retrospective population-based cohort study. We selected 900 patients with confirmed COPD aged ≥35 years by simple random sampling among all COPD patients in Cantabria (northern Spain) on December 31, 2011. We defined moderate exacerbations as events that led a care provider to prescribe antibiotics or corticosteroids and severe exacerbations as exacerbations requiring hospital admission. We observed exacerbation frequency over the previous year (2011) and following year (2012). We categorized patients according to COPD severity based on forced expiratory volume in 1 second (Global Initiative for Chronic Obstructive Lung Disease [GOLD] grades 1-4). We estimated the odds ratios (ORs) by logistic regression, adjusting for age, sex, smoking status, COPD severity, and frequent exacerbator phenotype the previous year.
Of the patients, 16.4% had ≥1 severe exacerbations, varying from 9.3% in mild GOLD grade 1 to 44% in very severe COPD patients. A history of at least two prior severe exacerbations was positively associated with new severe exacerbations (adjusted OR, 6.73; 95% confidence interval [CI], 3.53-12.83) and mortality (adjusted OR, 7.63; 95%CI, 3.41-17.05). Older age and several comorbidities, such as heart failure and diabetes, were similarly associated.
Hospitalized exacerbations occurred with all grades of airflow limitation. A history of severe exacerbations was associated with new hospitalized exacerbations and mortality.
慢性阻塞性肺疾病(COPD)急性加重对患者具有重大影响,且导致可观的医疗费用,尤其是在需要住院治疗的情况下。尽管住院急性加重很重要,但对其决定因素的了解相对较少。本研究旨在分析COPD患者住院急性加重和死亡的预测因素。
这是一项基于人群的回顾性队列研究。2011年12月31日,我们通过简单随机抽样在坎塔布里亚(西班牙北部)的所有COPD患者中选取了900例确诊的≥35岁的COPD患者。我们将中度急性加重定义为导致医护人员开具抗生素或皮质类固醇的事件,将重度急性加重定义为需要住院治疗的急性加重。我们观察了前一年(2011年)和次年(2012年)的急性加重频率。我们根据基于1秒用力呼气量的COPD严重程度对患者进行分类(慢性阻塞性肺疾病全球倡议[GOLD]1-4级)。我们通过逻辑回归估计比值比(OR),并对年龄、性别、吸烟状况、COPD严重程度和前一年的频繁急性加重表型进行校正。
在这些患者中,16.4%发生了≥1次重度急性加重,从轻度GOLD 1级的9.3%到极重度COPD患者的44%不等。至少有两次既往重度急性加重史与新的重度急性加重(校正OR,6.73;95%置信区间[CI],3.53-12.83)和死亡率(校正OR,7.63;95%CI,3.41-17.05)呈正相关。年龄较大以及合并几种疾病,如心力衰竭和糖尿病,也有类似的相关性。
所有级别的气流受限都会发生住院急性加重。重度急性加重史与新的住院急性加重和死亡率相关。